Key result
MINOCA patients show persistent 3-month LV-GLS impairment comparable to MIOCA despite preserved LVEF.
Why the study?
MINOCA represents a heterogeneous clinical entity, and this study aimed to evaluate the diagnostic and follow-up value of LV-GLS and its association with inflammatory and glycemic biomarkers.
Does left ventricular global longitudinal strain (LV-GLS) detect subclinical myocardial dysfunction and correlate with inflammatory and glycemic biomarkers over a 3-month follow-up in patients with MINOCA compared to MIOCA and INOCA?
Cohort (n=337)
No
Does left ventricular global longitudinal strain (LV-GLS) detect subclinical myocardial dysfunction and correlate with inflammatory and glycemic biomarkers over a 3-month follow-up in patients with MINOCA compared to MIOCA and INOCA?
In patients with MINOCA, left ventricular global longitudinal strain (LV-GLS) detects persistent subclinical myocardial dysfunction at 3 months despite preserved LVEF, with admission glucose and neutrophil-to-platelet ratio independently predicting strain impairment.
LV-GLS may identify persistent subclinical dysfunction in MINOCA despite preserved LVEF; leaves open whether routine strain assessment improves risk stratification or outcomes.
Background/Objectives: Myocardial infarction with non-obstructive coronary arteries (MINOCA) represents a heterogeneous clinical entity in which patients exhibit symptoms and biomarker evidence of myocardial infarction despite the absence of significant coronary stenosis. This study aimed to evaluate the diagnostic and follow-up value of left ventricular global longitudinal strain (LV-GLS) in patients with MINOCA and to investigate its association with inflammatory and glycemic biomarkers. Methods: A total of 287 patients presenting with acute coronary syndrome were prospectively enrolled. Based on coronary angiographic findings, patients were classified into two groups: myocardial infarction with obstructive coronary arteries (MIOCA; ≥50% stenosis, n = 237) and MINOCA (<50% stenosis, n = 50). In addition, an ischemic control group without obstructive disease (INOCA, n = 50) was included for comparative analysis. Laboratory tests, echocardiography, and LV-GLS were assessed at baseline and at 3 months. Results: Baseline left ventricular ejection fraction (LVEF) and LV-GLS were significantly lower in MIOCA compared with MINOCA (LVEF: 52.9 ± 10.3% vs. 59.7 ± 8.7%, p < 0.001; LV-GLS: −11.46 ± 4.84% vs. −12.63 ± 6.33%, p = 0.007, respectively). At 3 months, LVEF remained lower in the MIOCA group (57.5 ± 6.6% vs. 62.0 ± 7.9%; p < 0.001, respectively), whereas LV-GLS improved similarly in both groups with no significant difference (−15.27 ± 2.60% vs. −14.87 ± 5.21%; p = 0.29, respectively). Among MINOCA patients, the neutrophil-to-platelet ratio (NPR) (p = 0.017) and admission glucose (p = 0.047) were independently associated with impaired LV-GLS (defined as values greater than −16%). Conclusions: Although LVEF remained higher in MINOCA patients during follow-up, LV-GLS impairment persisted at levels comparable to those observed in MIOCA, suggesting ongoing subclinical myocardial dysfunction. LV-GLS offers superior diagnostic sensitivity to LVEF. Inflammatory and glycemic markers may aid in early risk stratification and guide management in patients with MINOCA.
No takes yet. Share an insight, caveat, or question.
Yavuz et al. (2026) conducted a cohort in Myocardial infarction with non-obstructive coronary arteries (MINOCA) and acute coronary syndrome (ACS) (n=337). Myocardial infarction with non-obstructive coronary arteries (MINOCA) evaluated by speckle-tracking echocardiography (LV-GLS) vs. Myocardial infarction with obstructive coronary arteries (MIOCA; ≥50% stenosis, n=237) and ischemic control group without obstructive disease (INOCA, n=50) was evaluated on Left ventricular global longitudinal strain (LV-GLS, %) at 3-month follow-up (p=0.29). In MINOCA patients, 3-month LV-GLS impairment persisted at levels comparable to MIOCA (-14.87% vs. -15.27%, p=0.29) despite higher preserved LVEF (62.0% vs. 57.5%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: